文献速递颈动脉与弓上血管

性别对颈动脉血运重建临床结局的影响

Clinical impact of sex on carotid revascularization.
PubMed 文献 · J Vasc Surg · 2020-02-01

基于VQI数据库2012–2017年83436例颈动脉内膜剥脱术(CEA)或颈动脉支架置入术(CAS)患者,比较男女围术期结局。女性术前抗血小板药和他汀使用较少;症状性CEA女性30天死亡风险更高,无症状CAS女性围术期卒中/死亡及院内卒中风险更高。

要点

  • 女性颈动脉疾病患者术前接受最佳药物治疗的比例低于男性。
  • 症状性CEA女性调整后30天死亡风险高于男性。
  • 无症状CAS女性围术期卒中/死亡及院内卒中风险高于男性。

核心结论

  • 女性颈动脉疾病患者较少接受抗血小板药和他汀的最佳药物治疗。
  • 症状性CEA女性与较高死亡率相关,无症状CAS女性与较高卒中/死亡风险相关。
  • 女性患者治疗时需谨慎选择患者,并开展质量改进项目消除药物治疗差异。

研究设计与样本

  • 回顾性队列研究,纳入Vascular Quality Initiative数据库中2012–2017年接受CEA或CAS的患者共83436例(CEA 71383例,CAS 12053例)。
  • 主要结局为围术期卒中/死亡,次要结局为院内卒中、30天死亡和院内心肌梗死。
  • 按治疗方式和症状状态分层比较男女围术期结局,并使用多变量回归校正基线特征差异。

主要发现

  • 无症状和症状性CEA女性术前抗血小板药使用率低于男性。
  • 女性总体术前他汀使用率较低,慢性阻塞性肺疾病患病率较高。
  • CAS队列中女性既往同侧CEA史比例较高。

临床怎么用

  • 应关注女性颈动脉疾病患者术前抗血小板药和他汀的规范使用。
  • 对症状性CEA女性及无症状CAS女性应加强围术期风险评估与患者选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The impact of sex in the management of carotid disease is unclear in the current literature. Therefore, we evaluated the effect of sex on perioperative outcomes following carotid endarterectomy (CEA) and carotid artery stenting (CAS). METHODS: We included patients who underwent CEA or CAS between 2012 and 2017 in the Vascular Quality Initiative database. Our primary outcome was perioperative stroke/death. Secondary outcomes were in-hospital stroke, 30-day mortality, and in-hospital MI. We compared perioperative outcomes between female and male patients, stratified by treatment modality and symptom status, and used multivariable regression to account for differences in baseline characteristics. RESULTS: A total of 83,436 patients underwent either a CEA (71,383) or CAS (12,053). Asymptomatic and symptomatic CEA females were less likely to be on a preoperative antiplatelet agent, when compared to males. Females overall, were less likely to be on a preoperative statin and more likely to have chronic obstructive pulmonary disease. Within the CAS cohort, females were more likely to have a previous ipsilateral CEA. There were no differences between males and females in major adverse events following CEA for asymptomatic disease. Following CEA for symptomatic disease, there was no difference in stroke/death rate or in-hospital stroke. However, females experienced a higher 30-mortality after adjustment (univariate: 1.0% vs 0.7%, P = .04; adjusted: odds ratio [OR], 1.4:1.02-1.94). Following CAS for asymptomatic disease, females experienced a higher rate of perioperative stroke/death (2.9% vs 1.9% P = .02; OR, 1.5: 1.05-2.03) and in-hospital stroke (2.1% vs 1.2% P = .01; OR, 1.8: 1.20-2.60). There were no differences in outcomes for symptomatic females vs males undergoing CAS. CONCLUSIONS: Females with carotid disease less frequently receive optimal medical treatment with antiplatelet agents and statins. This is an important target area for quality improvement issue in both females and males. Furthermore, among symptomatic CEA patients the female sex is associated with higher mortality and among asymptomatic CAS patients, females experience higher rates of stroke/death. These findings suggest that careful patient selection is necessary in the treatment of female patients. Quality improvement projects should be created to further investigate and eliminate the disparities of optimal medical management between the sexes.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Dansey KD, Pothof AB, Zettervall SL, et al. Clinical impact of sex on carotid revascularization. J Vasc Surg. 2020. PMID: 32014286. doi:10.1016/j.jvs.2019.07.088

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。